Search Results

Pharmacology and Toxicology of Cannabis Derivatives and Endocannabinoid Agonists

Authors: Gerra, Gilberto; Zaimovic, Amir; Gerra, Maria L.; Ciccocioppo, Roberto; Cippitelli, Andrea; Serpelloni, Giovanni; Somaini, Lorenzo

Source: Recent Patents on CNS Drug Discovery, Volume 5, Number 1, January 2010 , pp. 46-52(7)

Publisher: Bentham Science Publishers

Experimental Approaches Towards Allergic Asthma Therapy-Murine Asthma Models

Authors: Wegmann, Michael; Hauber, Hans P.

Source: Recent Patents on Inflammation & Allergy Drug Discovery, Volume 4, Number 1, January 2010 , pp. 37-53(17)

Publisher: Bentham Science Publishers

Synthesis and Pharmacological Evaluation of Analogs of Indole-Based Cannabimimetic Agents

Authors: Mazzoni, Orazio; Diurno, Maria V.; di Bosco, Antonio M.; Novellino, Ettore; Grieco, Paolo; Esposito, Giovanni; Bertamino, Alessia; Calignano, Antonio; Russo, Roberto

Source: Chemical Biology & Drug Design, Volume 75, Number 1, January 2010 , pp. 106-114(9)

Publisher: Blackwell Publishing

Proteinase-activated receptors 1and 2 mediate contraction of human oesophageal muscularis mucosae

Authors: chang, b.-s.; chang, j.-c.; huang, s.-c.

Source: Neurogastroenterology and Motility, Volume 22, Number 1, January 2010 , pp. 93-e32(-92)

Publisher: Blackwell Publishing

The Role of Toll-Like Receptors in Host Defenses and Their Relevance to Dermatologic Diseases

Authors: Terhorst, Dorothea; >Behnam Naderi Kalali,; Ollert, Markus; Ring, Johannes; Mempel, Martin

Source: American Journal of Clinical Dermatology, Volume 11, Number 1, 1 February 2010 , pp. 1-10(10)

Publisher: Adis International

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy

Authors: Fox, Norma Lynn; Humphreys, Robin; Luster, Troy A; Klein, Jerry; Gallant, Gilles

Source: Expert Opinion on Biological Therapy, Volume 10, Number 1, January 2010 , pp. 1-18(18)

Publisher: Informa Healthcare

Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study

Authors: Nachtigall, Lisa B.; Valassi, Elena; Lo, Janet; McCarty, David; Passeri, Jonathan; Biller, Beverly M. K.; Miller, Karen K.; Utz, Andrea; Grinspoon, Steven; Lawson, Elizabeth A.; Klibanski, Anne

Source: Clinical Endocrinology, Volume 72, Number 1, January 2010 , pp. 53-58(6)

Publisher: Blackwell Publishing

Thrombin-Activated Receptors: Promising Targets for Cancer Therapy?

Authors: Garcia-Lopez, M. T.; Gutierrez-Rodriguez, M.; Herranz, R.

Source: Current Medicinal Chemistry, Volume 17, Number 2, January 2010 , pp. 109-128(20)

Publisher: Bentham Science Publishers

Subcutaneous allergen immunotherapy restores human dendritic cell innate immune function

Authors: Tversky, J. R.; Bieneman, A. P.; Chichester, K. L.; Hamilton, R. G.; Schroeder, J. T.

Source: Clinical & Experimental Allergy, Volume 40, Number 1, January 2010 , pp. 94-102(9)

Publisher: Blackwell Publishing

Effect of age on cardiac excitation-contraction coupling

Authors: Fares, Elias; Howlett, Susan E

Source: Clinical and Experimental Pharmacology and Physiology, Volume 37, Number 1, January 2010 , pp. 1-7(7)

Publisher: Blackwell Publishing

Cabergoline therapy for prolactinomas: is valvular heart disease a real safety concern?

Authors: Vallette, Sophie; Serri, Karim; Serri, Omar

Source: Expert Review of Cardiovascular Therapy, Volume 8, Number 1, January 2010 , pp. 49-54(6)

Publisher: Expert Reviews

Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapy

Authors: McGowin, Chris L; Pyles, Richard B

Source: Future Microbiology, Volume 5, Number 1, January 2010 , pp. 15-22(8)

Publisher: Future Medicine

Design and application of locally delivered agonists of the adenosine A_2A receptor

Authors: Mantell, Simon; Jones, Rhys; Trevethick, Mike

Source: Expert Review of Clinical Pharmacology, Volume 3, Number 1, January 2010 , pp. 55-72(18)

Publisher: Expert Reviews

Pharmacotherapy for exercise-induced asthma: allowing normal levels of activity and sport

Author: Fitch, Kenneth D

Source: Expert Review of Clinical Pharmacology, Volume 3, Number 1, January 2010 , pp. 139-152(14)

Publisher: Expert Reviews

Editorial [Hot topic: The Search of Targets for Novel Antipsychotic Drugs (Executive Editor: Akihiro Takano)]

Author: Takano, Akihir

Source: Current Pharmaceutical Design, Volume 16, Number 3, January 2010 , pp. 308-308(1)

Publisher: Bentham Science Publishers

Treating the Cognitive Deficits of Schizophrenia with Alpha4Beta2 Neuronal Nicotinic Receptor Agonists

Authors: Radek, Richard J.; Kohlhaas, Kathy L.; Rueter, Lynne E.; Mohler, Eric G.

Source: Current Pharmaceutical Design, Volume 16, Number 3, January 2010 , pp. 309-322(14)

Publisher: Bentham Science Publishers

Cognitive Improvement by Activation of α7 Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology

Authors: Thomsen, Morten S.; Hansen, Henrik H.; Timmerman, Mikkelsen B.; Mikkelsen, Jens D.

Source: Current Pharmaceutical Design, Volume 16, Number 3, January 2010 , pp. 323-343(21)

Publisher: Bentham Science Publishers

Topical resiquimod: a promising adjuvant for vaccine development?

Authors: Igartua, Manoli; Pedraz, José Luís

Source: Expert Review of Vaccines, Volume 9, Number 1, January 2010 , pp. 23-27(5)

Publisher: Expert Reviews

Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism

Authors: Xi, Zheng-Xiong; Li, Xia; Peng, Xiao-Qing; Li, Jie; Chun, Lauren; Gardner, Eliot L.; Thomas, Ajit G.; Slusher, Barbara S.; Ashby Jr, Charles R.

Source: Journal of Neurochemistry, Volume 112, Number 2, January 2010 , pp. 564-576(13)

Publisher: Blackwell Publishing

Serotonin 5-HT3 and 5-HT4 Ligands: An Update of Medicinal Chemistry Research in the Last Few Years

Authors: Modica, M. N.; Pittala, V.; Romeo, G.; Salerno, L.; Siracusa, M. A.

Source: Current Medicinal Chemistry, Volume 17, Number 4, February 2010 , pp. 334-362(29)

Publisher: Bentham Science Publishers